ABSTRACT
Inositol-based compounds are central to many signal transduction pathways. For example, phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P 2 ] is a precursor for the phospholipase C product inositol 1,4,5-trisphosphate, which is a key regulator of intracellular calcium levels (1) . Moreover, PtdIns(4,5)P 2 is a substrate for phosphoinositide 3-kinase (PtdIns3K), which yields phosphatidylinositol 3,4,5-trisphosphate (PtdInsP 3 ). PtdIns3K is triggered by a wide range of growth factors and cytokines, and it and͞or its products contribute to the regulation of many cell functions, including cell proliferation, differentiation, and apoptosis (2) . However, although more than 30 inositol-containing phospholipids and inositol polyphosphates have been identified, relatively little is known about the roles of most of these compounds in cellular signaling.
Chloride (Cl Ϫ ) secretion by polarized epithelia at mucosal surfaces plays a key role in controlling salt and fluid secretion. In the intestine, for example, constitutive Cl Ϫ flux is important in the maintenance of normal hydration and provides solvent for extracellular solutes. Furthermore, Cl Ϫ and consequently water flux increase after infection with many enteric pathogens (e.g., Salmonella), and this host response contributes to the removal of the invading pathogen from the intestinal tract (3, 4) . Several pathways have been identified that stimulate Cl Ϫ secretion through the elevation of either cAMP or intracellular calcium levels, which act on separate apically located Cl Ϫ channels (5) . In addition, Cl (6) (7) (8) and (ii) epidermal growth factor (EGF) inhibits CaMCS through a PtdIns3K pathway (9, 10 ). Thus, the overall level of Cl Ϫ secretion is determined by a balance between stimulatory and inhibitory factors that act on the intestinal epithelium.
Invasive enteric bacteria enter and penetrate the intestinal epithelium to gain access to the underlying mucosa and initiate systemic infection. Bacterial entry into epithelial cells is an interactive process that requires bacterial and host cell signaling events (11, 12) and triggers epithelial cell responses that play a role in host protection against the invading bacteria (4, 13). A possible role for inositol polyphosphates in the epithelial response to bacterial invasion was suggested by earlier studies, in which Salmonella invasion elicited an overall increase in inositol polyphosphate turnover (14) , but the nature and source of these changes remained undefined. Because inositol polyphosphates are potentially important in cell signaling, we examined the changes in the levels of specific cellular inositol polyphosphates in response to Salmonella invasion of intestinal epithelial cells. The data show that infection of intestinal epithelial cells with Salmonella, but not other invasive bacteria, induces Ins(1,4,5,6)P 4 production. Furthermore, this inositol isomer has a function in epithelial cells by antagonizing signaling through PtdIns3K pathways. As a consequence, the negative regulation of CaMCS by EGF is antagonized, and could thereby contribute to the bacterially induced diarrhea.
Bioresearch (Leverkusen, Germany). Membrane-permeant analogues of PtdInsP 3 were prepared by total synthesis as will be described elsewhere (T.J., G. Sweeney, A. Klip, A.E.T.-K., and R.T., and C.S., M.T.R., H. H. Gillandt, and A.E.T.-K., unpublished work). The preparation of DiC 16 -BtPtdInsP 3 ͞AM was Ϸ5% DiC 16 -BtPtdInsP 3 ͞AM and 95% dipalmitoylglycerol whereas the preparations of DiC 8 -PtdInsP 3 ͞AM and DiC 12 -PtdInsP 3 ͞AM were Ͼ99% pure, as determined by proton nuclear magnetic resonance spectroscopy and positive ion mode electron spray mass spectroscopy. Radiolabeled inositol phosphates used as standards for HPLC were from NEN. Phosphatidylinositol for in vitro PtdIns3K assays was obtained from Avanti Polar Lipids. EGF was from Genzyme.
Cells. The T 84 human colon epithelial cell line (15) was maintained in 50% DMEM and 50% Ham's F-12 medium, supplemented with 5% newborn calf serum and 2 mM glutamine. The LS174T human colon adenocarcinoma cell line (CL 188) was obtained from the American Type Culture Collection and maintained in DMEM supplemented with 10% fetal calf serum, 10 mM Hepes, and 2 mM glutamine.
Bacterial Strains. The following bacteria were used in these studies (13, 16) : Salmonella dublin, Salmonella typhi BRD691 (an aroA͞aroC mutant that invades epithelial cells normally but does not replicate inside the cells), Yersinia enterocolitica, enteroinvasive Escherichia coli (serotype O29:NM), enterohemorrhagic E. coli (serotype O157), Shigella dysenteriae, Shigella flexneri, and nonpathogenic E. coli DH5␣ (GIBCO͞BRL). Bacteria were grown and prepared for infection as described before (13, 16) . H]inositol (specific activity 80-120 Ci͞mmol; Amersham) in inositol-free 50% DMEM, 50% Ham's F-12 medium, supplemented with 5% dialyzed newborn calf serum. Cultures were washed three times with prewarmed medium (50% DMEM͞50% Ham's F-12 medium͞1 mg/ml BSA) and infected with 5 ϫ 10 8 bacteria͞well using the same medium for various periods of time. Cultures were washed twice with ice-cold PBS and lysed for 5 min on ice in 0.5 ml͞well 10% trichloroacetic acid͞10 mM phytic acid, and extracts were neutralized using 1,1,2-trichlorotrif luoroethane͞tri-n-octylamine. [ 3 H]inositol polyphosphates in the extracts were separated on an Adsorbosphere SAX column (Alltech Associates), and the radioactive peaks were quantitated as described before (17) . (6) . Rat hepatic Ins(1,4,5,6)P 4 3-kinase was purified 240-fold, with a yield of 3%, by Mono Q (Pharmacia) anion-exchange chromatography (18) followed by blue A affinity chromatography and Ins(1,4,5)P 3 affinity chromatography (A. Craxton, M. Hirata, and S.B.S., unpublished data). The enzyme preparation did not phosphorylate Ins(3,4,5,6)P 4 . The [ 33 P]Ins(1,4,5,6)P 4 standard was prepared by dephosphorylation of [ 33 P]Ins(1,3,4,5,6)P 5 by using multiple inositol polyphosphate phosphatase (19) .
[ 33 P]Ins(1,3,4,5,6)P 5 was purified from turkey erythrocytes that were labeled radioactively by using methods described before except that [ 33 P]P i was used instead of [ Ussing Chamber Experiments. T 84 cells were seeded onto microporous filter inserts (Snapwells, Costar) and grown to confluence for 7-12 days. The inserts were mounted into modified Ussing chambers (Physiologic Instruments, San Diego), bathed with Ringer's solution warmed to 37°C and gassed continuously with 95% O 2 ͞5% CO 2 at a rate of 30-35 ml͞min. The spontaneous potential difference across the monolayer was short-circuited with a voltage clamp (model VCC MC6, Physiologic Instruments). Short circuit current (I sc ) and conductance were recorded at 4-s intervals by using ACQUIRE AND ANALYSE software 1.1 (Physiologic Instruments). Increased I sc stimulated through cholinergic pathways (e.g., after carbachol addition) in T 84 cells is wholly reflective of Cl Ϫ secretion (21).
[Ca 2ϩ ] i levels were elevated with carbachol (100 M) applied to the medium bathing the basolateral side of the monolayers.
PtdIns3K Assays. PtdIns3K activity was measured in antiPtdIns3K (rabbit polyclonal anti-85K subunit, Upstate Biotechnology, Lake Placid, NY) or mouse monoclonal antiphosphotyrosine (clone 4G10, Upstate Biotechnology) immunoprecipitates exactly as described (10) . For experiments to determine the effect of Ins(1,4,5,6)P 4 on PtdIns3K activity in vitro, T 84 cells were stimulated with EGF (16.3 nM) for 1 and 5 min, and PtdIns3K was immunoprecipitated and resuspended in reaction buffer (10) . Ins(1,4,5,6)P 4 (200 M) was added 10 min before addition of [␥-32 P]ATP. Wortmannin (50 nM) was used as a control. 4 (enantiomers that cannot be resolved by HPLC) increased within 10 min after S. dublin infection, reaching a 14-fold maximum 30 -40 min after infection (Fig. 1) . After enantiomeric analysis, this peak was found to consist primarily of Ins(1,4,5,6)P 4 ( Fig. 1) . We estimate that the intracellular concentrations of Ins(1,4,5,6)P 4 and Ins(3,4,5,6)P 4 were 4.7 and 0.9 M, respectively, 30 min after S. dublin infection, based on our prev ious determinations of the resting levels of Ins(1,4,5,6)P 4 and Ins(3,4,5,6)P 4 in T 84 cells (6) and the relative increase of these enantiomers after infection. Levels of Ins(1,4,5,6)P 4 decreased slowly after 40 min and returned to near baseline by 3 h after infection ( Table 1) . The elevation in [ 3 H]Ins(1,4,5,6)P 4 levels was accompanied by a parallel decline in [ 3 H]InsP 5 levels, reaching a minimum of 50% of control levels 30 -60 min after infection (Fig. 1b) and by smaller increases in an InsP 3 isomer (labeled Z in Fig. 1a ) and two InsP 2 isomers (labeled X and Y in Fig. 1a) . Compounds X, Y, and Z did not match elution patterns of available inositol phosphate standards. Similar observations (Table 1) . Furthermore, addition to T 84 monolayers of noninvasive Gram-negative bacteria such as enterohemorrhagic E. coli (serotype O157) or a nonpathogenic E. coli (strain DH5␣) or addition of bacterial lipopolysaccharide, also had little to no effect on [ (Table 1) .
RESULTS

Salmonella
Ins(1,4,5,6)P 4 Inhibits EGF-Induced Inhibition of CalciumMediated Cl
؊ Secretion in Intestinal Epithelial Cells. We next investigated the functional relationship between the Salmonella-induced changes in Ins(1,4,5,6)P 4 levels and the secretory response to the infection. Such studies in bacteria-infected cells are hampered by the asynchronous nature of the infection with Salmonella and by the fact that a variable proportion of epithelial cells in tissue culture become infected. In addition, Salmonella infection is likely to have other effects on epithelial cells that would complicate the identification of a role for Ins(1,4,5,6)P 4 . To circumvent these problems, we raised Ins(1,4,5,6)P 4 levels in resting T 84 cells by using membranepermeant D-2,3-di-O-butyr yl-myo-inositol 1,4,5,6-tetrakisphosphate octakis(acetoxymethyl) ester (Bt 2 Ins(1,4,5,6)P 4 ͞ AM), which diffuses into epithelial cells and subsequently is hydrolyzed by ubiquitous, nonspecific cellular esterases to release Ins(1,4,5,6)P 4 (6) . As a functional assay for these experiments, we assessed the effect of Ins(1,4,5,6)P 4 on transepithelial Cl Ϫ secretion across polarized T 84 monolayers mounted in Ussing chambers.
We found previously that Bt 2 Ins(1,4,5,6)P 4 ͞AM had no effect on Cl Ϫ secretion by itself, nor did it affect [Ca 2ϩ ] i levels (6). Furthermore, Bt 2 Ins(1,4,5,6)P 4 ͞AM neither potentiated nor inhibited the effects of known agonists of Cl bition of CaMCS (9) . Addition of Bt 2 Ins(1,4,5,6)P 4 ͞AM to T 84 monolayers significantly reversed inhibition of CaMCS that was induced by EGF preincubation (Fig. 2 a and b) . In contrast, this inhibitory EGF function was not attenuated by addition of membrane-permeant esters of Ins (1,3,4 ,5,6)P 5 (Fig. 2c) or Ins(3,4,5,6)P 4 (data not shown), the latter being the enantiomer of Ins(1,4,5,6)P 4 . These findings demonstrate that Ins(1,4,5,6)P 4 can, in an enantiomerically specific manner, up-regulate CaMCS by reversing EGF-mediated inhibition of this process. Furthermore, the Ins(1,4,5,6)P 4 action was specific for CaMCS because addition of Bt 2 Ins(1,4,5,6)P 4 ͞AM to T 84 monolayers did not reverse EGF inhibition of cAMP-mediated Cl Ϫ secretion (data not shown).
Ins(1,4,5,6)P 4 Antagonizes Phosphoinositide 3-Kinase Signaling Pathways in Epithelial Cells. The Ins(1,4,5,6)P 4 effect on EGF-mediated inhibition of CaMCS is similar to that reported for the PtdIns3K inhibitor wortmannin (10) . This raised the possibility that Ins(1,4,5,6)P 4 might interact with PtdIns3K signaling pathways. We first investigated whether PtdIns3K activity itself was affected by Ins(1,4,5,6)P 4 . However, addition of up to 200 M Ins(1,4,5,6)P 4 had no effect on the activity of immunoprecipitated PtdIns3K in vitro (data not shown). Furthermore, Ins(1,4,5,6)P 4 did not inhibit PtdIns3K activation after EGF stimulation of T 84 cells because assays of PtdIns3K activity (see Materials and Methods) showed that EGF stimulated this activity in Bt 2 Ins(1,4,5,6)P 4 ͞AM-treated cells as much, or more, than it did in control cells [the ratio of PtdIns3K activity in EGFstimulated relative to basal activity in unstimulated control cells was 3.3-fold in Bt 2 Ins(1,4,5,6)P 4 ͞AM-pretreated cells and 2.7-fold in untreated cells (n ϭ 2); these values fall within the range of those reported (10)].
We next tested whether Ins(1,4,5,6)P 4 acted downstream of PtdIns3K. PtdInsP 3 is a major product of PtdIns3K in EGFstimulated T 84 cells, and our previous studies suggested that PtdInsP 3 , or one of its metabolites, mediated the EGF effects on CaMCS (10). To test this hypothesis directly, three membranepermeant analogues of PtdInsP 3 were synthesized: dipalmitoyl DL-6-O-butyryl-PtdIns(3, 4, 5)P 3 ͞AM (DiC 16 (Fig. 2 d and e) but had no effect on [Ca 2ϩ ] i levels after carbachol stimulation (T.J., G. Sweeney, A. Klip, A.E.T.-K., and R.T., unpublished work). Inhibition of CaMCS by DiC 12 -PtdInsP 3 ͞AM was dosedependent, with 38.5 Ϯ 3.8% inhibition (mean Ϯ SEM, n ϭ 4) after incubation with 20 M of the ester and 17% inhibition (mean, n ϭ 2) after incubation with 2 M ester. The maximal inhibition of CaMCS by the membrane-permeant forms of PtdInsP 3 was comparable to that observed after EGF stimulation of T 84 cells (9) . Furthermore, addition of EGF to monolayers preincubated with DiC 12 -PtdInsP 3 ͞AM did not result in additional inhibition of CaMCS (data not shown), indicating that PtdInsP 3 and EGF work through the same mechanism. We then tested if co-incubation of monolayers with Bt 2 Ins(1,4,5,6)P 4 ͞AM and either DiC 16 -BtPtdInsP 3 ͞AM or DiC 8 -PtdInsP 3 ͞AM would reverse the effect of membrane-permeant PtdInsP 3 on CaMCS. As shown in Fig. 2d , preincubation of T 84 monolayers with membrane-permeant forms of both Ins(1,4,5,6)P 4 and PtdInsP 3 led to significantly less inhibition of CaMCS than preincubation with membrane-permeant PtdInsP 3 alone. In contrast, preincubation with a membrane-permeant form of Ins(1,3,4,5,6)P 5 did not affect inhibition of CaMCS by PtdInsP 3 (Fig. 2e) .
DISCUSSION
These findings represent the first evidence that a physiologically relevant stimulus, the entry of Salmonella into colonic epithelia, elicits the elevation of Ins(1,4,5,6)P 4 levels. The changes in (17) , which suggests that the effects of Salmonella invasion on inositol phosphate levels are independent of phospholipase C. Furthermore, elevated Ins(1,4,5,6)P 4 levels have been attributed to constitutive src activation in transformed fibroblasts (23) , but tyrosine kinases were not involved in the Salmonella-induced Ins(1,4,5,6)P 4 increase because specific tyrosine kinase inhibitors (genistein, herbimycin A, and tyrphostin A25) did not affect this cellular response (data not shown). Therefore, Salmonella appears to affect inositol phosphate metabolism through a unique mechanism. The fact that S. dublin did not alter InsP 6 levels and the demonstration of reciprocal changes in the levels of InsP 5 and Ins(1,4,5,6)P 4 , together suggest that S. dublin infection might activate a phosphatase, such as multiple inositol polyphosphate phosphatase (previously inositol polyphosphate 3-phosphatase) (19) , to dephosphorylate InsP 5 to Ins(1,4,5,6)P 4 (as schematically depicted in Fig. 3, left) . Our data suggest that Ins(1,4,5,6)P 4 prevents EGF from inhibiting CaMCS in polarized epithelial cells by antagonizing a PtdInsP 3 signaling pathway. Transforming growth factor ␣, which, like EGF, binds to and activates the EGF receptor, is constitutively expressed in intestinal epithelial cells (24) and inhibits Cl Ϫ secretion through a PtdIns3K pathway (data not shown). Tonic inhibition through this pathway could be counteracted by the Salmonella-induced increase in Ins(1,4,5,6)P 4 (as schematically shown in Fig. 3, right) . Such a mechanism would be expected to act early after infection and mostly in those epithelial cells that are infected with Salmonella and could result in diarrhea although other mechanisms also contribute to this outcome (3, 4, 25) . Moreover, because Ins(1,4,5,6)P 4 disinhibits CaMCS, this inositol polyphosphate, or an analogue, may be useful in treating cystic fibrosis, in which mucosal Cl Ϫ secretion is reduced and depends primarily on CaMCS (26) . Because our data indicate that the effect of Ins(1,4,5,6)P 4 on Cl Ϫ secretion was downstream of PtdIns3K, it is possible that Ins(1,4,5,6)P 4 competes with PtdInsP 3 for effector binding sites because Ins(1,4,5,6)P 4 is a partial structural analog of the PtdInsP 3 headgroup (27) . As a result, Ins(1,4,5,6)P 4 could compete with phosphoinositide binding to pleckstrin homology domains of signaling proteins and inhibit the normal recruitment of signal transduction complexes to the plasma membrane (28, 29) .
